Q1 2023 Excelsior Newsletter
Drug Trends to Watch, Actions to Consider by Robert Kordella, RPh, MBASenior Vice President and Chief Clinical Officer DIABETES Rising prescription costs related to the
March 16, 2023
No Comments
ICER Update 10.04.22
Hello everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. ICER released a Final Evidence Report assessing the comparative clinical effectiveness and value
October 8, 2022
No Comments
Q3 2022 Excelsior Newsletter
Excelsior’s Opinion on So-Called “Vision Enhancement Products” by Robert Kordella, RPh, MBA, Chief Clinical Officer Three products have come to market recently that are being
September 29, 2022
No Comments